12.07.2015 Views

Morphological subtypes of ovarian carcinoma: a ... - BPA Pathology

Morphological subtypes of ovarian carcinoma: a ... - BPA Pathology

Morphological subtypes of ovarian carcinoma: a ... - BPA Pathology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SUBTYPES OF OVARIAN CARCINOMA 427same way as endometrioid <strong>carcinoma</strong>s 20 (see later). Mostprimary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>s are well or moderatelydifferentiated (grade 1 or 2) and confined to the ovary.Occasionally, especially in the context <strong>of</strong> a borderline mucinousneoplasm, there is a sharp demarcation between a borderlinearea and a solid cellular area, a so-called mural nodule. 70,71The mural nodules may be benign (either sarcoma-like composed<strong>of</strong> a mixture <strong>of</strong> osteoclast-like giant cells, inflammatorycells and mononuclear cells or corresponding to some specificbenign neoplasm such as leiomyoma, rhabdomyoma or haemangioma)or malignant. The malignancy is most commonlyanaplastic <strong>carcinoma</strong> but may be sarcoma or carcinosarcoma. 70The anaplastic <strong>carcinoma</strong> may be composed <strong>of</strong> spindled,pleomorphic or rhabdoid cells. 70 It is likely that some previouslyreported examples <strong>of</strong> sarcoma-like mural nodulesactually represent anaplastic spindle cell <strong>carcinoma</strong> and cytokeratinsstains may be useful in confirming this.Immunohistochemistry <strong>of</strong> primary <strong>ovarian</strong> mucinous<strong>carcinoma</strong>sAs discussed, most primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>s (andborderline tumours) are <strong>of</strong> so-called intestinal type. Intestinaltype <strong>ovarian</strong> mucinous neoplasms are typically diffuselypositive with CK7 but also commonly express, focally ordiffusely, enteric markers such as CK20, CDX2, CEA andCA19.9 and are negative with hormone receptors, CA125 andWT1. 72,73 CA19.9 especially is <strong>of</strong>ten diffusely positive andthere may be elevation <strong>of</strong> the serum level <strong>of</strong> this marker. 74Serum CA19.9 levels may be extremely high and are <strong>of</strong> novalue in predicting preoperatively whether an <strong>ovarian</strong> mucinousneoplasm is benign, borderline or malignant. 74Molecular events in primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>sSimilar to low grade serous <strong>carcinoma</strong>s, <strong>ovarian</strong> mucinoustumours <strong>of</strong> intestinal type commonly exhibit k-ras mutationsand identical mutations have been demonstrated in benign,borderline and malignant areas within the same neoplasm,suggesting that k-ras mutation is an early event in the evolution<strong>of</strong> these tumours. 75–77 Unlike low grade serous <strong>carcinoma</strong>s,b-raf mutations are not a feature <strong>of</strong> <strong>ovarian</strong> mucinousneoplasms <strong>of</strong> intestinal type.Behaviour <strong>of</strong> primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>sAs discussed previously, most primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>s<strong>of</strong> intestinal type are unilateral and stage I. Advancedstage (stage III or IV) primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>sare very rare and a secondary should always be excluded. Theprognosis <strong>of</strong> stage I primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong> isrelatively good, although some cases recur, usually in the pelvisor abdomen; recurrence is associated with a poor prognosis. Inone recent population-based study <strong>of</strong> 31 primary <strong>ovarian</strong>mucinous <strong>carcinoma</strong>s, eight <strong>of</strong> 31 recurred. 65 Infiltrative stromalinvasion is associated with a worse prognosis than expansileinvasion. Advanced stage primary <strong>ovarian</strong> mucinous <strong>carcinoma</strong>shave a dismal prognosis and respond poorly to thetraditional chemotherapeutic agents used to treat <strong>ovarian</strong> <strong>carcinoma</strong>s.However, it is again stressed that these are extremelyuncommon. Malignant mural nodules are usually associatedwith a poor prognosis, although a recent study has shown thatstage 1A tumours with malignant mural nodules may beassociated with a relatively favourable outcome. 70ENDOMETRIOID ADENOCARCINOMAMost, but not all, <strong>ovarian</strong> endometrioid adeno<strong>carcinoma</strong>s arelow grade and low stage (usually confined to the ovary, stage I).They are usually unilateral but approximately 10% are bilateral.They <strong>of</strong>ten, although not always, arise from endometriosis(especially an endometriotic cyst) or a pre-existing borderlineaden<strong>of</strong>ibroma. 78,79 The prevalence <strong>of</strong> primary <strong>ovarian</strong> endometrioidadeno<strong>carcinoma</strong> is lower in recent than in olderstudies. 7,8 This is almost certainly due to the recognition thatmany neoplasms which were previously diagnosed as highgrade and high stage endometrioid <strong>carcinoma</strong>s are, in fact,serous in type. This is an area where previously there was poorreproducibility amongst pathologists and where WT1 stainingmay be useful (discussed later). With an endometrioid adeno<strong>carcinoma</strong>involving the ovary, there is not uncommonly asynchronous endometrioid proliferation, either premalignant ormalignant, within the uterine corpus. 80 If conservative management(unilateral salpingo-oophorectomy) is undertaken for astage I <strong>ovarian</strong> endometrioid adeno<strong>carcinoma</strong>, the endometriumshould be sampled to exclude significant pathology here.Diagnosing a low grade endometrioid adeno<strong>carcinoma</strong> isusually straightforward, although problems may arise in thedistinction between a grade 1 endometrioid adeno<strong>carcinoma</strong>and a borderline endometrioid aden<strong>of</strong>ibroma. 79 Some lowgrade endometrioid adeno<strong>carcinoma</strong>s exhibit obvious stromalinvasion but in many (probably the majority) the diagnosis ismade on the basis <strong>of</strong> a back-to-back glandular architecture withexclusion <strong>of</strong> stroma, similar to the criteria used to diagnose anendometrioid adeno<strong>carcinoma</strong> <strong>of</strong> the endometrium (Fig. 7).The presence <strong>of</strong> glandular confluence and a back-to-backarchitecture with stromal exclusion should result in a diagnosis<strong>of</strong> endometrioid adeno<strong>carcinoma</strong> even when the cytologicalfeatures are low grade. The presence <strong>of</strong> one or more <strong>of</strong> theimportant triad <strong>of</strong> aden<strong>of</strong>ibromatous areas, squamous elements(morular or non-morular) and endometriosis may be a usefulpointer towards an endometrioid neoplasm. Unusual morphologicalfeatures occasionally seen in <strong>ovarian</strong> endometrioidadeno<strong>carcinoma</strong>s, either focally or diffusely, include sexcord-like formations and spindle cell differentiation; thesefeatures also occur more uncommonly in the correspondinguterine neoplasms. 81 The other morphological variants <strong>of</strong>uterine endometrioid adeno<strong>carcinoma</strong>, such as secretory andoxyphilic, may also occur in the ovary. High grade <strong>ovarian</strong>Fig. 7 Low grade endometrioid adeno<strong>carcinoma</strong> <strong>of</strong> ovary with back to backglandular arrangement.Copyright © Royal College <strong>of</strong> pathologists <strong>of</strong> Australasia. Unauthorized reproduction <strong>of</strong> this article is prohibited.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!